Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
SIGA SIGA Technologies
24.750
-0.040-0.16%
Post Mkt Price
24.650
-0.1-0.40%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Total revenue
92.61% 16.67M 118.94% 10.54M 6.97% 133.67M 205.75% 115.36M
Operating revenue
92.61% 16.67M 118.94% 10.54M 6.97% 133.67M 205.75% 115.36M
Cost of revenue
136.88% 7.72M 223.73% 8.27M 3.14% 26.54M 137.29% 17.41M
Gross profit
65.85% 8.94M 0.54% 2.27M 7.97% 107.13M 222.28% 97.95M
Operating expense
8.94% 5.87M -12.67% 3.71M 22.49% 18.03M 9.25% 3.92M
Selling and administrative expenses
12.62% 5.87M -13.27% 3.52M 23.71% 17.32M 10.49% 3.75M
Other operating expenses
-- -- -0.04% 193.26K -1.25% 710.15K -11.9% 174.66K
Operating profit
278548.91% 3.07M 27.67% -1.44M 5.43% 89.09M 250.8% 94.02M
Net non-operating interest income expense
0 0
Non-operating interest expense
-- -- -- -- -- 0 -- 0
Other net income (expense)
-73.86% 121.93K -60.35% 374.43K 102.75% 218.94K 72.58% -151.66K
Gain on sale of security
-88.79% 49.56K -61.79% 351.1K 103.34% 117.77K 71.3% -176.78K
Special income (charges)
-- -- -- -- -- 0 -- 0
Other non- operating income (expenses)
198.63% 72.37K -8.78% 23.32K -80.99% 101.17K -60.04% 25.12K
Income before tax
582.76% 3.19M -1.86% -1.06M 21.5% 89.31M 257.61% 93.87M
Income tax
287.25% 1.16M -201.98% -703.41K 15.7% 19.86M 239.42% 20.67M
Net income
1103.94% 2.04M 55.54% -361.05K 23.27% 69.45M 263.1% 73.21M
Net income continuous Operations
1103.94% 2.04M 55.54% -361.05K 23.27% 69.45M 263.1% 73.21M
Minority interest income
Net income attributable to the parent company
1103.94% 2.04M 55.54% -361.05K 23.27% 69.45M 263.1% 73.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1103.94% 2.04M 55.54% -361.05K 23.27% 69.45M 263.1% 73.21M
Basic earnings per share
1244.09% 0.03 50.59% -0.0049 29.58% 0.92 273.08% 0.97
Diluted earnings per share
988.1% 0.03 50% -0.01 28.17% 0.91 269.23% 0.96
Dividend per share
Currency Unit
USDUSDUSDUSD
Audit Opinions
----Unqualified Opinion with Explanation--

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
CEO: Gomez III, M.D., Ph.D., Phillip Louis
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top